Asset Details
Do you wish to reserve the book?
Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage
Do you wish to request the book?
Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage
2012
Overview
Background
In Scotland colorectal cancer (CRC) is the third most common cancer and a leading cause of cancer death. Epidemiological studies have reported conflicting associations between statins and CRC risk and there is one published report of the association between statins and CRC survival.
Methods
Analysis was carried out on 309 cases and 294 controls from the Scottish Study of Colorectal Cancer (SOCCS). Cox’s hazard and logistic regression models were applied to investigate the association between statin use and CRC risk and survival.
Results
In an adjusted logistic regression model, statins were found to show a statistically significant association for three of the four statin variables and were found to not show a statistically significant association with either all-cause or CRC-specific mortality (OR 0.49; 95%CI 0.49-1.36; p-value = 0.17 and OR 0.33; 95%CI 0.08-1.35; P-value = 0.12, respectively).
Conclusion
We did find a statistically significant association between statin intake and CRC risk but not statin intake and CRC-specific mortality. However, the study was insufficiently powered and larger scale studies may be advisable.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Biomedical and Life Sciences
/ Cancer
/ Colorectal Neoplasms - epidemiology
/ Colorectal Neoplasms - mortality
/ Female
/ Health Promotion and Disease Prevention
/ Humans
/ Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage
/ Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects
/ Male
/ Oncology
/ Risk
/ Statins
/ Studies
